Allison Fiscalini

Director, Athena Breast Prog.
Surgery
+1 415 476-0267
Publications: 

Validation study of risk-reduction activities after personalized breast cancer education tool in the WISDOM study.

NPJ breast cancer

Wang T, Che M, Huilgol YS, Keane H, Goodman D, Soonavala R, Ozanne E, Shieh Y, Belkora JK, Fiscalini AS, Athena Breast Health Network Investigators and Advocate Partners, Esserman LJ

Receiving a pathogenic variant in a population breast cancer screening trial: a mixed method study.

Public health genomics

Riddle L, James JE, Naeim A, Madlensky L, Brain S, De Rosa D, Eklund M, Fiscalini AS, Heditsian D, Koenig B, Ross K, Sabacan LP, Tong B, Wenger N, Joseph G

Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment Education Tool in High-Risk Women in the WISDOM Study.

Research square

Esserman L, Wang T, Che M, Huilgol Y, Keane H, Goodman D, Soonavala R, Ozanne E, Shieh Y, Belkora J, Fiscalini AS

Correction to: Social support as a moderator of healthcare adherence and distress in long-term hematopoietic cell transplantation survivors.

Journal of cancer survivorship : research and practice

Nørskov KH, Yi JC, Crouch ML, Fiscalini AS, Flowers MED, Syrjala KL

The WISDOM study: a new approach to screening can and should be tested.

Breast cancer research and treatment

Esserman L, Eklund M, Veer LV, Shieh Y, Tice J, Ziv E, Blanco A, Kaplan C, Hiatt R, Fiscalini AS, Yau C, Scheuner M, Naeim A, Wenger N, Lee V, Heditsian D, Brain S, Parker BA, LaCroix AZ, Madlensky L, Hogarth M, Borowsky A, Anton-Culver H, Kaster A, Olopade OI, Sheth D, Garcia A, Lancaster R, Plaza M

Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry.

NPJ breast cancer

Huilgol YS, Keane H, Shieh Y, Hiatt RA, Tice JA, Madlensky L, Sabacan L, Fiscalini AS, Ziv E, Acerbi I, Che M, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, Parker BA, van 't Veer LJ, Athena Breast Health Network Investigators and Advocate Partners, Esserman LJ

Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial.

NPJ breast cancer

Keane H, Huilgol YS, Shieh Y, Tice JA, Belkora J, Sepucha K, Shibley WP, Wang T, Che M, Goodman D, Ozanne E, Fiscalini AS, Esserman LJ

Social support as a moderator of healthcare adherence and distress in long-term hematopoietic cell transplantation survivors.

Journal of cancer survivorship : research and practice

Nørskov KH, Yi JC, Crouch ML, Fiscalini AS, Flowers MED, Syrjala KL

Response to Carter et al.

JNCI cancer spectrum

Eklund M, Broglio K, Yau C, Connor JT, Fiscalini AS, Esserman LJ

Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Syrjala KL, Crouch ML, Leisenring WM, Flowers MED, Artherholt SB, Fiscalini AS, Romano E, Romano JM, Martin PJ, Yi JC

An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation.

Journal of cancer survivorship : research and practice

Syrjala KL, Yi JC, Artherholt SB, Romano JM, Crouch ML, Fiscalini AS, Hegel MT, Flowers MED, Martin PJ, Leisenring WM

Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes.

Annals of surgical oncology

Wang F, Peled AW, Garwood E, Fiscalini AS, Sbitany H, Foster RD, Alvarado M, Ewing C, Hwang ES, Esserman LJ

Patient-reported outcomes and satisfaction after total skin-sparing mastectomy and immediate expander-implant reconstruction.

Annals of plastic surgery

Peled AW, Duralde E, Foster RD, Fiscalini AS, Esserman LJ, Hwang ES, Sbitany H